trending Market Intelligence /marketintelligence/en/news-insights/trending/zja4ugd3xiz6y2rshgf9dg2 content esgSubNav
In This List

Alkermes appoints president/COO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Alkermes appoints president/COO

James Robinson will become Alkermes plc's president and COO on March 5.

He will lead the Dublin-based company's global commercial, business development and human resources functions as it expands its commercial portfolio to advance treatments for central nervous system disorders.

Robinson was previously the president of Americas operations at Astellas US LLC, a subsidiary of Astellas Pharma Inc.

He has more than 25 years of biopharmaceutical industry experience.